Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial Cystitis.

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 appendix a supplementary data to this article can be found online at https://doi org/10 1016/j euros2023 07 006 ."

"

 Financial disclosures: Yoshiyuki Akiyama certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. Financial disclosures:"

"

Financial disclosures: Yoshiyuki Akiyama certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. 

Funding/Support and role of the sponsor: This study was supported by a KAKENHI Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS; grant number 22K16788 to Yoshiyuki Akiyama), and by a Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare (grant number 21446301 to Yukio Homma). The sponsor played a role in the design and conduct of the study, collection, management, analysis and interpretation of the data and preparation of the manuscript."